| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38a202259af9cd163ad244e02e11ea37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74e43c9cdc8c1c3d13b98df21bb40585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54b53f56bdd09d6422661be342a77e83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f861d7dfdde7b233339d4838364a8e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22d73c17a144819ecddc4dae43e784f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68ae70b4ea2e795f0a4ecec832a0ac83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a2dfc384c04173d5e26cb2411a44b58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| filingDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a4cea2957afa146cb14b86c437d9050
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f9deb4e764da899843876e0619b5c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66719d04dd4ba619d1c97bb0d5024381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60156aa71f1b9fe92f6418ec7f12f599
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1932d9822d5370bea370ac024eca35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65ade1b0678e68361c28406067e91d48 |
| publicationDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006000069-A1 |
| titleOfInvention |
Pharmaceutical compositions consisting of cyclodextrin and an antimony derivative, their preparation as well as their use |
| abstract |
The present invention comprises processes of preparation of compounds between cyclodextrins and antimony derivatives, pharmaceutical compositions containing these compounds and methods that take advantage of these compositions for improving mainly the oral, cutaneous and percutaneous absorption of antimony. The present invention also presents therapeutic alternatives for leishmaniases and schistosomiasis based on the use of compounds between cyclodextrins and antimony derivatives by oral route and in topical application. |
| priorityDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |